Replies to post #146618 on Biotech Values

[mcbio]

Let’s wait until Wednesday, when ACHN is holding its 2Q12 CC.

Yep, will definitely give a listen. Olek resigned shortly after the Phase 2a data for sovaprevir so you wonder if the two could have been connected. ACHN does still have ACH-2684 and the NS5A candidates as well, though.